irritable bowel syndrome

The companies aim to develop microbiome diagnostic assays for colon cancer and other gastrointestinal diseases including irritable bowel syndrome.

Qualified patients will have immediate access to IQuity's MS test, with expected access later to an IBD-IBS test, and a fibromyalgia test.

The agreement, with Genetic Analysis of Oslo, involves technology to detect gut dysbiosis and investment for additional tests.

The researchers used this approach to show how non-coding variation associated with human immune dysfunction alters context-specific gene programs. 

IQuity's current tests analyze gene expression patterns detected in mRNA, but the firm is also exploring the diagnostic potential of long non-coding RNAs.

The test, which detects various bacterial species in fecal samples, is expected to be submitted to US regulators before the end of this year.

Genetic Analysis CEO Kari Stenersen said the deal is a "commercial breakthrough" for the Oslo-based company.

NEW YORK (GenomeWeb News) – The nonprofit Crohn's and Colitis Canada has awarded nearly C$800,000 (US$740,000) to fund three omics research projects that will investigate genes involved in inflammatory bowel diseases (IBD) and a possible method for treating such diseases.

NEW YORK (GenomeWeb) – An international team that includes members of the "Metagenomics of the Human Intestinal Tract," or MetaHIT, consortium has come up with a new method for putting together microbial genomes and identifying species from metagenomic sequence data.

Pages

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.